Skip to content

S. Schmidt

2 papers in the library · 159 citations · publishing 2019-2021

Papers

Sort Most recent Most cited

Mindfulness-Based Cognitive Therapy as Migraine Intervention: a Randomized Waitlist Controlled Trial

International Journal of Behavioral Medicine December 21, 2021 K. Simshäuser, R. Pohl, P. Behrens et al.

Based on promising effects seen in a pilot study evaluating a generic mindfulness-based program for migraine, we developed a migraine-specific adaptation of the Mindfulness-Based Cognitive Therapy (MBCT) program. The aim of this study was to evaluate this program for feasibility and effectiveness in a randomized controlled trial. Fifty-four patients suffering from migraine were randomly...

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

Proceedings of the National Academy of Sciences of the United States of America February 22, 2019 E. Lumsden, Timothy A. Troppoli, S. J. Myers et al. 159 citations

Significance Standard antidepressant treatments require weeks to show effectiveness. A single subanesthetic dose of ketamine rapidly attenuates many clinical signs and symptoms of depression; however, ketamine treatment also has many adverse effects, including dissociation and potential for abuse, which are mediated by NMDA glutamate receptor (NMDAR) inhibition. Previous work has revealed that...